胎儿胸腔积液与先天性肺病变的胸腔羊膜腔分流术:系统综述与荟萃分析
该系统综述纳入45项研究、1976例接受胸腔羊膜腔分流术(TAS)的胎儿,总结围产期结局。胸腔积液胎儿死胎率8.3%、围产期死亡率29.5%;先天性肺病变对应为6.6%和22.6%。分流相关并发症包括分流管移位和阻塞,早产未足月胎膜早破和<37周分娩率较高。
要点
- TAS与产前胸腔减压相关,可能促进积液和水肿消退。
- 胸腔积液胎儿围产期死亡率29.5%,先天性肺病变22.6%。
- 分流管移位和阻塞常见,<37周分娩率分别达64.3%和41.6%。
核心结论
- TAS可能与产前胸腔减压相关,并可能促进部分病例积液和水肿消退。
- 与历史数据的间接比较提示TAS可能降低死亡率。
- 需标准化选择标准并开展前瞻性或多中心研究。
研究设计与样本
- 系统综述与单臂随机效应荟萃分析,检索MEDLINE、CINAHL、Cochrane CENTRAL、Web of Science、Scopus和EMBASE,从建库至2025年11月6日。
- 纳入45项研究,共1976例接受TAS的胎儿。
- 采用Downs and Black量表进行质量和偏倚风险评估,使用广义线性混合效应模型生成合并比例及95%CI。
主要发现
- 胸腔积液胎儿死胎合并比例为8.3%(95%CI 5.8–11.6%),围产期死亡为29.5%(95%CI 26.4–32.7%)。
- 先天性肺病变胎儿死胎合并比例为6.6%(95%CI 3.5–12.1%),围产期死亡为22.6%(95%CI 13.2–35.9%)。
- 胸腔积液胎儿分流管移位13.2%(95%CI 8.8–19.4%),分流管阻塞或故障14.1%(95%CI 9.1–21.1%)。
- 先天性肺病变胎儿分流管移位10.2%(95%CI 4.3–22.3%),分流管阻塞或故障8.6%(95%CI 2.8–23.4%)。
- 胸腔积液胎儿TAS后早产未足月胎膜早破19.3%(95%CI 13.8–26.4%),<37周分娩64.3%(95%CI 58.1–70.2%)。
关键数值与推荐
- 胸腔积液胎儿水肿消退率为63.3%(95%CI 52.9–72.6%)。
- 先天性肺病变胎儿水肿消退率为95.1%(95%CI 82.5–98.8%)。
- 先天性肺病变胎儿TAS后早产未足月胎膜早破15.4%(95%CI 5.9–34.5%),<37周分娩41.6%(95%CI 29.4–54.8%)。
临床怎么用
- 对于选择性胎儿胸腔积液或先天性肺病变病例,TAS可作为产前胸腔减压的干预选项。
- 咨询时应告知分流管移位、阻塞、早产未足月胎膜早破和早产的风险。
- 需结合水肿状态和原发诊断个体化评估获益与风险。
局限性
- 纳入研究多为单臂设计,缺乏同期对照,结论基于与历史数据的间接比较。
- 原文未报告各研究间具体异质性来源的详细分析。
- 需前瞻性或多中心研究验证标准化选择标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Objective To summarize reported outcomes associated with thoracoamniotic shunting (TAS) in fetuses with pleural effusion or congenital lung lesions. Methods We conducted a search across MEDLINE, CINAHL, Cochrane CENTRAL, Web of Science, Scopus, and EMBASE databases, from inception to 6 November 2025, for studies reporting the incidence of perinatal outcomes after TAS in pregnancies complicated by fetal pleural effusion or congenital lung lesions. Quality and risk-of-bias assessments were performed utilizing the Downs and Black scale. Single-arm random-effects meta-analyses with generalized linear mixed-effects models were performed to generate pooled proportions with 95% CI. Heterogeneity was assessed using Cochran's Q and quantified by the I 2 statistic. Subgroup analyses were conducted according to the primary diagnosis (pleural effusion or congenital lung lesions). Results Overall, 45 studies, including 1976 fetuses that underwent TAS, were included in the systematic review. Among fetuses with pleural effusion, the pooled proportion of fetal death was 8.3% (95% CI, 5.8–11.6%) (I 2 = 18.1%) and that of perinatal death was 29.5% (95% CI, 26.4–32.7%) (I 2 = 27.7%). In cases of congenital lung lesion, the corresponding pooled proportions were 6.6% (95% CI, 3.5–12.1%) (I 2 = 0%) and 22.6% (95% CI, 13.2–35.9%) (I 2 = 0%), respectively. Shunt-related complications included shunt displacement (13.2% (95% CI, 8.8–19.4%) in cases of pleural effusion and 10.2% (95% CI, 4.3–22.3%) in cases of congenital lung lesion) and shunt obstruction or malfunction (14.1% (95% CI, 9.1–21.1%) and 8.6% (95% CI, 2.8–23.4%), respectively). Preterm prelabor rupture of membranes after TAS was reported in 19.3% (95% CI, 13.8–26.4%) of cases of pleural effusion and 15.4% (95% CI, 5.9–34.5%) of cases of congenital lung lesion, and birth < 37 weeks occurred in 64.3% (95% CI, 58.1–70.2%) and 41.6% (95% CI, 29.4–54.8%) of cases, respectively. In hydropic fetuses, resolution of hydrops was achieved in 63.3% (95% CI, 52.9–72.6%) of cases of pleural effusion and 95.1% (95% CI, 82.5–98.8%) of cases of congenital lung lesion. Conclusions TAS in fetuses with pleural effusion or congenital lung lesions is associated with prenatal thoracic decompression and may contribute to resolution of pleural effusion and hydrops in selected cases, with indirect comparisons with historical data suggesting a possible reduction in mortality. Standardized selection criteria and prospective and/or multice
引用
- Ultrasound in Obstetrics and Gynecology:Thoracoamniotic shunting for fetal pleural effusion and congenital lung lesions: systematic review and meta‐analysis
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。